EVAX
Evaxion Biotech AS
NASDAQ: EVAX · HEALTHCARE · BIOTECHNOLOGY
$4.41
+3.52% today
Updated 2026-04-30
Market cap
$33.61M
P/E ratio
—
P/S ratio
4.47x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $12
Volume
0.0M
Evaxion Biotech AS (EVAX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.99M | $-7.03M | $-12.44M | $-21.93M | $-25.77M | $-17.69M | $-12.94M | $-6.65M |
| Capital expenditures | $7000.00 | $61000.00 | $393000.00 | $1.36M | $292000.00 | $87000.00 | $4.00 | $11034.00 |
| Depreciation | $74000.00 | $81000.00 | $105000.00 | $344000.00 | $571000.00 | $615000.00 | $607000.00 | — |
| Stock-based comp | $2.07M | $2.36M | $3.41M | $1.38M | $942000.00 | $479000.00 | $357000.00 | $307000.00 |
| Free cash flow | $-2.00M | $-7.09M | $-12.83M | $-23.29M | $-26.07M | $-17.78M | $-12.94M | $-6.66M |
| Investing cash flow | $6000.00 | $-68000.00 | $-393000.00 | $-1.33M | $-268000.00 | $-93000.00 | $-3000.00 | — |
| Financing cash flow | $9.03M | $9.51M | $8.82M | $49.80M | $7.85M | $10.69M | $13.13M | — |
| Dividends paid | — | $165000.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |